Asthma Attacks Face Newly Approved Super Treatment ‘Cinqair’ – The Inquisitr


The Inquisitr

Asthma Attacks Face Newly Approved Super Treatment 'Cinqair'
The Inquisitr
Asthma attacks have a new opponent. And from clinical reports, asthma treatment Cinqair may be quite the formidable remedy. Although, there are side effects. Humans need adequate air flows in order to function properly. Yet, asthma's objective goes
FDA approves Cinqair to treat severe asthmaFDA.gov
FDA approves new drug Cinqair to be used against AsthmaTampa Bay Review
Reslizumab (Cinqair) Approved to Treat Severe AsthmaMedscape
The Hoops News –MedPage Today
all 72 news articles »

View full post on asthma – Google News

Asthma Attack Faces Newly Approved Super Treatment ‘Cinqair’ – The Inquisitr


The Inquisitr

Asthma Attack Faces Newly Approved Super Treatment 'Cinqair'
The Inquisitr
Asthma attacks have a new opponent. And from clinical reports, asthma treatment Cinqair may be quite the formidable remedy. Although, there are side effects. Humans need adequate air flows in order to function properly. Yet, asthma's objective goes
FDA approves Cinqair to treat severe asthmaFDA.gov
Reslizumab (Cinqair) Approved to Treat Severe AsthmaMedscape
Teva's Cinqair Approved for Severe AsthmaMedPage Today
The Hoops News –Pharmacy Today, American Pharmacists Association, pharmacist.com
all 70 news articles »

View full post on asthma – Google News

Asthma Treatment Market for the period 2015–2021, Report Examines by Persistence Market Research (PMR) – Medgadget.com (blog)

Asthma Treatment Market for the period 2015–2021, Report Examines by Persistence Market Research (PMR)
Medgadget.com (blog)
logo395 Asthma is a chronic inflammatory lung disease. Asthma affects personnel in all ages but mostly starts in childhood. Asthma creates inflammation in the inside walls of airways which makes airways very sensitive for the allergic reaction. Asthma

and more »

View full post on asthma – Google News

New Inhaled Asthma Treatment, SPIRIVA RESPIMAT, Now Available in US – Lung Disease News


Lung Disease News

New Inhaled Asthma Treatment, SPIRIVA RESPIMAT, Now Available in US
Lung Disease News
Boehringer Ingelheim Pharmaceuticals recently announced that SPIRIVA RESPIMAT, a new inhaled medicine for maintenance treatment of asthma, is now available by prescription in U.S. pharmacies for adults and adolescents. The U.S. Food and Drug …
SPIRIVA® RESPIMAT® Now Available in the US for Maintenance Treatment of Asthma in Adults and AdolescentsBusiness Wire India (press release)

all 2 news articles »

View full post on asthma – Google News

Asthma Treatment Market (2015 – 2021): The report provides in-depth analysis of parent market trends, macro … – Medgadget.com (blog)

Asthma Treatment Market (2015 – 2021): The report provides in-depth analysis of parent market trends, macro
Medgadget.com (blog)
PMR_New_logo_Final57 Asthma is a chronic inflammatory lung disease. Asthma affects personnel in all ages but mostly starts in childhood. Asthma creates inflammation in the inside walls of airways which makes airways very sensitive for the allergic …

View full post on asthma – Google News

Asthma Treatment Drugs Market In China Growth & Trends: Radiant Insights, Inc – Medgadget.com (blog)

Asthma Treatment Drugs Market In China Growth & Trends: Radiant Insights, Inc
Medgadget.com (blog)
This study focuses on China's Asthma Treatment Drugs industry assessments and company profiles. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities and rising consumer …

and more »

View full post on asthma – Google News

SPIRIVA® RESPIMAT® Now Available in the U.S. for Maintenance Treatment of Asthma in Adults and Adolescents – Business Wire (press release)

SPIRIVA® RESPIMAT® Now Available in the U.S. for Maintenance Treatment of Asthma in Adults and Adolescents
Business Wire (press release)
INGELHEIM, Germany–(BUSINESS WIRE)–Boehringer Ingelheim today announced that SPIRIVA® RESPIMAT® is now available for the treatment of asthma by prescription in U.S. pharmacies. The U.S. Food and Drug Administration (FDA) approved a …

and more »

View full post on asthma – Google News

SPIRIVA ® RESPIMAT ® Now Available in the US for Maintenance Treatment of Asthma in Adults and Adolescents – Business Wire (press release)

SPIRIVA ® RESPIMAT ® Now Available in the US for Maintenance Treatment of Asthma in Adults and Adolescents
Business Wire (press release)
INGELHEIM, Germany–(BUSINESS WIRE)–Boehringer Ingelheim today announced that SPIRIVA® RESPIMAT® is now available for the treatment of asthma by prescription in U.S. pharmacies. The U.S. Food and Drug Administration (FDA) approved a …
SPIRIVA RESPIMAT Now Available in the US for Maintenance Treatment of Asthma in Adults and AdolescentsThe FINANCIAL

all 2 news articles »

View full post on asthma – Google News